Development of VIII inhibitors beyond 50 exposure days to rFVIII during prophylactic emicizumab therapy.
Yuichi MitaniMamoru HondaYoshitaka MizushimaMakiko MoriKohei FukuokaKoichi OshimaYuki ArakawaKatsuaki TairaYutaka TanamiKatsuyoshi KohPublished in: Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Keyphrases